John R Applegate, MD in Wenatchee, WA - Anesthesiology

John R Applegate, MD is a Anesthesiology physician based in Wenatchee, Washington. John R Applegate is licensed to practice in Washington (license number MD00010465) and his current practice location is 1201 S Miller St, Wenatchee, Washington. He can be reached at his office (for appointments etc.) via phone at (509) 662-1511.

NPI number for John R Applegate is 1366481533 and his current mailing address is Po Box 34940, Seattle, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1366481533.

Contact Information

	John R Applegate, MD
	1201 S Miller St, Wenatchee, WA 98801-3201
	(509) 662-1511
	Not Available

Physician's Profile

Full Name	John R Applegate
Gender	Male
Speciality	Anesthesiology
Location	1201 S Miller St, Wenatchee, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1366481533
Provider Enumeration Date: 06/05/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for John R Applegate such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1366481533	NPI	-	NPPES
8252603	Medicaid	WA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	MD00010465 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John R Applegate is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John R Applegate, MD Po Box 34940, Seattle, WA 98124-1940 Ph: (503) 372-2740	John R Applegate, MD 1201 S Miller St, Wenatchee, WA 98801-3201 Ph: (509) 662-1511

News Archive

Substance use disorder treatment for workers without health insurance promotes safe and productive workplaces

An estimated 3 million full-time workers in America without health insurance (16.3 percent of all full-time workers without health care insurance) needed substance use treatment in the past year according to a national survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA). Levels of need were particularly high among those in this category who were aged 18 to 25 (24.4 percent) and males (19.2 percent).

CVS investigated by FTC over business practices

"CVS Caremark Corp (CVS.N) has been the subject of a U.S. Federal Trade Commission investigation over some of its business practices since August, the company said on Thursday," Reuters reports. "Various groups have asked the government to look into CVS Caremark's practices since drugstore chain CVS bought pharmacy benefits management business Caremark Rx Inc in March 2007. They claim that changes to services in the pharmacy benefits business since the acquisition have led to higher prices, compromised quality of care and pushed patients to choose CVS drugstores over other pharmacies."

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new data from Professor Isabelle Leclercq of Université Catholique de Louvain (Belgium) demonstrating the curative effects of GFT505 in an experimental model of NASH associated with metabolic disorders.

Walking could improve quality of life for patients with advanced cancer, study finds

Walking for just 30 minutes three times per week could improve the quality of life for those with advanced cancer, a new study published in the BMJ Open journal has found.

New technology reveals cellular gene transcription process in detail

A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.

Anesthesiology Doctors in Wenatchee, WA

Deborah M. Witham, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711
David C. Wiggum, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711
Jeb A. Sorom, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711
Garrett Wolter, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711
Dr. Rudy Wayne Linterman, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711
John F. Colpitts, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711
Peter W. Valaas, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711

John R Applegate, MD - Anesthesiology in Wenatchee, WA